Exploring the Link Between Gut Microbiota and Neuroinflammation in Autism Spectrum Disorder
Research highlights the role of gut microbiota imbalance and neuroinflammation in Autism Spectrum Disorder, suggesting potential therapeutic avenues involving the gut-brain axis.
Gut Microbiota-Derived 5-HTP Shows Potential to Improve Autism Symptoms in Animal Models
New research indicates that 5-HTP produced by gut bacteria may cross into the brain and reduce autism-related behaviors in animal models, highlighting a potential therapeutic pathway.
Study Links TMAO Miscompartmentalization to Autism Spectrum Disorder and Explores Potential Treatment
Research reveals that altered distribution of microbiota-derived TMAO may contribute to autism spectrum disorder, with urea showing potential as a therapeutic agent in animal models.